ChOlanGiography Performed Routinely Versus Selectively During Cholecystectomy: A NAtional Registry-based Randomized Controlled Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKarolinska Institutet

About this trial

Common bile duct stones (CBDS) may be asymptomatic but can cause pancreatitis, obstructive jaundice, and/or cholangitis. In Sweden, intraoperative cholangiography (IOC) is usually performed during gallstone surgery in order to detect CBDS and proactively extract them. The intervention to extract them may, however, cause complications by itself such as pancreatitis, bleeding, or perforation. In many countries, IOC is performed selectively when CBDS are suspected preoperatively (by patient history, imaging, or blood tests), or if the anatomy is unclear. There is a knowledge gap regarding the relation between risks associated with refraining from IOC and, thus, leaving undetected CBDS in situ, or actively diagnosing and removing the stones.

To compare these risks, we propose a national multicenter randomized controlled trial. The study will be embedded in the Swedish Registry for Gallstone Surgery (GallRiks), which will include all variables for inclusion and follow-up.

Population: Patients undergoing gallstone surgery without suspicion of CBDS Intervention: IOC Control: No IOC Outcome: Readmission or reintervention (Clavien-Dindo grade ≥IIIa) related to the cholecystectomy within 12 months after the operation.

A total of 6000 patients will be recruited. The results will have the potential to provide level A evidence for routines used in gallstone surgery not only in Sweden, but also internationally.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients undergoing cholecystectomy

Disqualifiers

Preoperative suspicion of common bile duct stone

Pregnancy

Age <18 years

Preoperative suspicion of malignancy in the gallbladder or bile ducts

Trial design

Design model

Parallel

Treatments tested in this trial

  • Routine cholangiography

    Procedure/Surgery

    Intraoperative cholangiography attempted regardless of indication and anatomy

  • Selective cholangiograpy

    Procedure/Surgery

    Intraoperative cholangiography only attempted in case of uncertainty regarding anatomy

Treatment groups

6,000 Participants
are divided into 2 treatment groups
Group A: Routine cholangiographyActive comparator 1 intervention
Group B: Selective cholangiographyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Reintervention within 12 months

Readmission and/or any type of surgical, endoscopic or radiological reintervention (corresponding to Clavien-Dindo grade 3a or higher), related to the cholecystectomy within 12 months after the cholecystectomy

Time frame
12 months

Secondary outcomes

1

Procedure time

Time required to complete the cholecystectomy

Time frame
12 hours
2

Mortality

Death within one year after surgery

Time frame
One year
3

Hospital stay

Cumulative hospital stay, including all admissions within one year after surgery

Time frame
One year
4

Health-related quality of life

Health-related quality of life assessed with SF-36

Time frame
Six months after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Karolinska Institutet

Lead sponsor

Research department, Ersta Hospital

Collaborator

Stockholm South General Hospital

Collaborator